SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " disorder " 100 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Health services may be missing the link between alcohol problems and eating disorders, study suggests
A review led by Bournemouth University researchers has highlighted the extent to which people seeking help for alcohol problems may also be struggling with a second, hidden problem with food and eating. ...
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
For patients living with chronic blood disorders, access to safe and reliable blood supplies is fundamental to their care journey. Marking the sixth edition of an impactful partnership, Bristol Myers Squibb proudly collaborated with the Emirates Thalassemia Society and Dubai Science Park, the region's leading science focused hub and part of TECOM Group PJSC, hosted the 'Help Save a Life' blood donation drive, bringing together community members and healthcare professionals to provide vital suppo
Sylvester Stallone ‘became bulimic’ during body ‘obsession,’ had 2.6 percent body fat ahead of “Rocky III”
The actor explained how he eventually “broke the cycle” of his eating disorder.
Healthy aging via good oral health? Maybe.
Periodontal therapy may be key to preventing cognitive decline and promoting healthy aging, a new study reports. The study proposes that chronic inflammation predisposes one to neurodegenerative disorders.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
What to know about menopause and mental health
In honor of Menopause Awareness Month, mental health expert and physician's assistant Rebecca Barbee joins us to discuss how menopause can intensify emotional challenges for women living with mental illnesses including bipolar disorder.
Mental Health Monday: Resources for those in recovery
Chelsea Bly, Associate Director of Children’s Services at Valley Health, joined Holly Baratta to tell us about substance abuse disorder in West Virginia and the resources available to take the first steps towards recovery.
Former LA business owner speaks out on leaving the city after years of disorder
Former Los Angeles business owner Paul Scrivano discusses the city's decline and continued disorder on 'America Reports.'
Men are hiding potentially deadly disorder amid pressure to build the 'perfect' body
Sylvester Stallone's bulimia revelation spotlights a crisis experts say is surging among men and boys driven by looksmaxxing and musculature ideals.
Daniela Lozano, M.D., Joins Baptist Health Kenneth C. Griffin Neuroscience Institute as a Headache Neurologist - Florida Hospital News and Healthcare Report
October 9, 2026 – Board-certified and fellowship-trained neurologist Daniela Lozano, M.D., has joined Baptist Health Kenneth C. Griffin Neuroscience Institute. Her clinical interests include migraine and other headache disorders, women’s […]
Preteens, phones and a hidden health risk
A study found 70% of kids they followed owned a smartphone by age 12. The kids reported at least one symptom of an eating disorder by 14.
Scientists discover a surprising link between vitamin C and cancer survival
A surprising clinical trial suggests that taking vitamin C daily could improve survival in people with precancerous blood disorders and early-stage blood cancers. Patients receiving the supplement had fewer adverse events and showed a promising survival advantage, raising hopes that a common vitamin could help protect against leukemia-related complications.
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
For patients living with chronic blood disorders, access to safe and reliable blood supplies is fundamental to their care journey. Marking the sixth edition of an impactful partnership, Bristol Myers Squibb proudly collaborated with the Emirates Thalassemia Society and Dubai Science Park, the region's leading science focused hub and part of TECOM Group PJSC, hosted the 'Help Save a Life' blood donation drive, bringing together community members and healthcare professionals to provide vital suppo
New framework maps the complex link between psychological status and cardiovascular health
CVD remains the leading cause of death worldwide, while the global burden of mental disorders continues to rise.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Kate Beckinsale Shares Cryptic “I Give Up” Message on Instagram, Leaving Fans Concerned
The posts came weeks after the actress opened up about her experience with post-traumatic stress disorder.
Milania Giudice Shares Bipolar Disorder Mental Health Struggles
"I am not ashamed of any of my mental health disorders because I'm currently at a treatment center,“ the young reality TV star said on social media.
New guided search tool helps Kentuckians navigate treatment, mental health and recovery resources
By Leah Dick University of Kentucky Finding the right support for substance use disorder treatment, mental health care, recovery housing or naloxone distribution can be an important step toward better…
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
GLP-1 Drugs and Mental Health: Effects on Depression and Anxiety
GLP-1 receptor agonists affect pathways involved in mood, appetite, and reward, prompting research into their potential benefits for depression, substance use disorders, and binge eating. Psychiatric treatment benefits remain unproven, while conflicting observational findings and reassuring trial evidence require careful interpretation.
Jeff Garlin details ‘nervous breakdown,’ undiagnosed bipolar disorder while on “The Goldbergs”: ‘I was going to commit suicide’
Five years after his breakdown, Garlin said he is “just now feeling really good.”
Worried About Your Teen? Check Their Dental Exam Results For A Window Into Their Well-Being
By Dennis Thompson HealthDay ReporterMONDAY, Oct. 19, 2026 (HealthDay News) — You can tell a lot about your teen from their oral health, says a new American Academy of Pediatrics (AAP) report. Many teenage health problems — eating disorders, smoking, drug use, sexually transmitted diseases — can be ...
Jenna Ortega details her most intense and specific OCD symptoms
Jenna Ortega is opening up about the repetitive actions that she performs as part of her struggles with obsessive compulsive disorder.
Scientists discover how deep sleep builds muscle, burns fat, and boosts the brain
Scientists have discovered a surprising two-way relationship between sleep and growth hormone, revealing how the brain carefully balances physical recovery with wakefulness. The findings could help explain why poor sleep harms metabolism and brain health, potentially opening the door to new treatments for sleep and neurological disorders.
Sylvester Stallone opens up about steroid use, eating disorder
Sylvester Stallone achieved peak fitness during his “Rocky” years and beyond, but at a price paid in steroid use and an eating disorder, he revealed in a new interview. What
Why does lithium work against bipolar disorder?
Lithium remains the gold standard for one of the most complex psychiatric conditions. Scientists are still getting to grips with why.
Scientists create a needle-thin brain implant that can do three jobs at once
A new needle-thin brain implant can record neural activity, deliver drugs, and stimulate multiple brain regions using a single flexible fiber. Successful tests in mice suggest it could give scientists a more precise, less invasive way to study the brain and may eventually help treat neurological disorders such as epilepsy.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Global life expectancy nears pre-pandemic level, but healthy years lag behind: WHO
Healthy life loss linked to anxiety disorders up nearly 45% since 2019, while depressive disorders see around 20% jump, says UN agency | Anadolu
Black Men, Mental Health and the Entertainment Industry
Black men, mental health and entertainment collide as Charlamagne Tha God and Lil Nas X open up about anxiety, trauma and bipolar disorder, while therapist Jahthaime Smith examines the pressures behind the public spotlight.
Is it your personality or a psychological disorder? TikTok has answers.
Maladaptive daydreaming, obsessional jealousy and misophonia are now topics of study as social media trends force psychiatrists to rethink their diagnostic “bible.”
Demi Lovato shares emotional update on eating disorder recovery
Demi Lovato has come a long way with their eating disorder recovery, but the journey is far from over.
GOP gubernatorial candidate pitches plan to lower property taxes
Charles, an attorney and former federal official, said he will also work with the federal government to increase funding for things like substance use disorder treatment.
Behind bars and beyond capacity: The mental health crisis in prisons
Open Access Government reflects on data and efforts from concerning the prevalence and care of mental health disorders among prisoners
Tackling mental health issues
In a world of chaos and disorder, maintaining your mental health has never been more important.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Dementia risk more than quadruples among adults with common disorder
Adults with ADHD had more than four times the risk of dementia or mild cognitive impairment, a University of Pittsburgh study of 187,000 people found.
Global Health & WASH: October 2026 Funding Opportunities (26 new opportunities)
41 opportunities on the Global Health & WASH page this cycle, 26 of them new. The health money on this page is mostly research money, and much of it is aimed at people early in their careers. Funder after funder, from the TANGO2 Research Foundation’s Research Pathways grants to the South African Medical Research Council’s Early Investigators Programme to the National Ataxia Foundation and Alex’s Lemonade Stand Foundation, is funding early-career investigators and the institutions that host them, with a clear tilt toward researchers based in or from the Global South, from AMBSO in Uganda to Kenya’s CONNECT-VAX network to Ersilia’s AI Incubator for African drug discovery. The money is organized by disease as much as by need: narrow foundations, the Parkinson’s Foundation, NTAP for neurofibromatosis, the RUNX1 Research Program for an inherited blood disorder, each run their own grant, so the question for an applicant is less which health problem you work on than which foundation owns your disease. The largest European cheques go to consortia only, with the European Innovation Council putting up to EUR €4 million behind a single healthy-ageing project and UNITE up to EUR €1 million behind each cross-border digital health team. Water sits apart, almost entirely in applied utility research: the Water Research Foundation’s cluster of USD $250,000 to $500,000 projects, each built around a utility problem from sewer laterals to reuse treatment. And the biggest single pot is public: HRSA is renewing community health center service areas with awards of up to USD $10 million each. This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Opportunities 2027 Building the Field of Health Advocacy Grant, Georgia Health Initiative. *New!* *Closing soon!* Georgia Health Initiative, a nonprofit private foundation focused on health equity, is opening its 2027 Building the Field of Health Advocacy Grant to strengthen the organizations that push for healthier systems across the state. The Initiative treats advocacy as infrastructure, backing one-year projects that range from urgent responses to shifting federal policy to longer arc campaigns on housing, behavioral health, care access, and food security. It wants coalitions that elevate community voice, apply an equity lens, and arrive ready to deploy concrete strategies, and it deliberately seeks variety in issues, communities, and organizational size. The optional webinar and required lobbying training signal a funder investing in a durable field, not one grant cycle. The strongest fits are Georgia nonprofits and public agencies ready to turn advocacy readiness into systems change. Geographies: United States. Who can apply: Tax-exempt 501(c)(3) public charities, state or local government agencies, or coalitions/collaboratives using a 501(c)(3) fiscal sponsor, that work in Georgia on behalf of Georgians and align with the mission, vision, and values of Georgia Health Initiative. Only one application per organization, though an organization may be listed as a partner or subcontractor on multiple applications. Funding amount: Organizations can apply for up to USD $80,000 per project; the Initiative anticipates investing a total of USD $1.36 million. Targeted Sectors / SDGs: Governance, Policy & Advocacy · SDG3; SDG10. Deadline: October 2, 2026. Learn more and apply here. TDD Research Pathways Grant, TANGO2 Research Foundation. *New!* *Closing soon!* The TANGO2 Research Foundation, working with a founding gift from Tango2UK, is opening its TDD Research Pathways Grant to fund early-career investigators anywhere in the world who study TANGO2 Deficiency Disorder. The foundation is using this money to seed pilot work and to build a research community around a rare disorder that few labs currently study. It wants to back emerging scientists, clinicians, and trainees who will stay with this field, not one-off projects, which is why it requires a committed mentor and real institutional support and asks each applicant for a plan for future contributions. The design rewards promise and persistence over track record. The strongest fits are students, residents, postdoctoral fellows, and new investigators ready to commit to TANGO2 research. Geographies: Global. Who can apply: Early-career investigators worldwide, including undergraduate, graduate, and medical trainees, postdoctoral fellows, residents, and clinical or research fellows. Early-career investigators must hold a PhD, MD, or equivalent doctoral degree and be within 10 years of that degree or within 5 years of initiating rare disease research, engaged in postdoctoral research at an academic institution, teaching hospital, or nonprofit research institute. Currently enrolled trainees and transitional PhD candidates beginning a postdoctoral appointment at a nonprofit institution by July 1, 2026 are also eligible. All applicants must identify a qualified mentor with relevant TDD or rare disease research experience and demonstrate institutional support. Funding amount: Up to USD $15,000. Targeted Sectors / SDGs: Innovation, Science & Technology. Deadline: October 2, 2026. Learn more and apply here. Call for Expression of Interest (EOI): AMBSO Impact Research Initiative, Africa Medical and Behavioral Sciences Organization (AMBSO). *Closing soon!* The Africa Medical and Behavioral Sciences Organization is inviting expressions of interest for its Impact Research Initiative, which funds early-stage pilot studies and proof of concept work on priority health challenges. AMBSO is a Ugandan research organization backing bold ideas that can grow into larger studies, and its tracks span antimicrobial resistance, epidemic preparedness, artificial intelligence for diagnostics, HIV prevention, climate and health, cancer, maternal and child health, and non-communicable diseases. The small award size and direct-cost-only rule point to a funder that wants evidence rather than overhead, and that favors projects able to attract follow-on money or use AMBSO’s own research infrastructure. Eligibility runs worldwide, welcoming researchers and institutions inside and outside Africa. The strongest fits are researchers with a feasible pilot that generates policy-ready evidence. Geographies: Global. Who can apply: Open worldwide to researchers, academic institutions, and research organizations whose work aligns with generating high-impact health evidence. Independent researchers are eligible if affiliated with an academic or research institution. Doctoral students are encouraged to apply as part of a research team led by a faculty Principal Investigator. Community-based organizations and other eligible entities may apply. Projects may be implemented inside or outside Uganda. Funding amount: Up to USD $10,000 per project, with no minimum funding threshold. Targeted Sectors / SDGs: SDG3. Deadline: October 2, 2026. Learn more and apply here. Entrepreneurs for Resilience 2027 (E4R27), Swiss Re Foundation. *Closing soon!* Swiss Re Foundation is opening the tenth edition of Entrepreneurs for Resilience, which backs healthcare social enterprises expanding affordable, quality primary care for low-income communities across low- and middle-income countries. The Foundation is using catalytic, blended funding plus multi-year advisory to take risk out of scaling, helping proven models reach more people sustainably rather than stay stuck at pilot size. It looks to back brick-and-click enterprises that pair physical care with digital tools and build affordability through savings, payments, or microinsurance, ideally integrated with public health systems. Requiring earned revenue, real customer scale, and gender-inclusive teams signals that this is growth capital for commercially serious ventures, not seed money. The strongest fits are established, revenue-generating healthcare enterprises ready to scale access for underserved populations. Geographies: Global. Who can apply: For-profit and hybrid healthcare social enterprises serving low-income and underserved populations in low- and middle-income countries, using combined physical and digital (brick-and-click) healthcare delivery models. Applicants must demonstrate measurable social impact, generate at least 50% of income through earned revenue, have been established no later than December 2023, already serve at least 50,000 people with potential to scale, and have at least 30% low-income customers. Preference for gender-inclusive enterprises with at least one female founder or at least 30% women in management. Funding amount: Pilot funding of up to USD $45,000 for the 6-8 shortlisted social enterprises; up to USD $1 million in blended funding (up to USD $600,000 unconditional plus up to USD $400,000 conditional) shared among 3-4 finalists over a two-year implementation period; total programme funding approximately USD $1.3 million. Targeted Sectors / SDGs: Innovation, Science & Technology · SDG3; SDG5. Deadline: October 4, 2026. Learn more and apply here. Horizon HealthTech 2026, IIITD Innovation & Incubation Center. *Closing soon!* IIITD Innovation and Incubation Center is opening Horizon HealthTech 2026, a nine-month MedTech incubation cohort run under the aegis of BIRAC EDGE for founders building medical devices, diagnostics, surgical and interventional tools, or remote monitoring. The center is backing teams that already hold a validated proof of concept and want to reach a tested prototype, pairing each founder with a named expert and clinical validation through a hospital partner. What they seek to back is Indian health technology that can survive real clinical scrutiny and regulatory review, not slideware. The structure, with lab access, CDSCO guidance, IP support, and investor connects, signals a program built to make startups ready for follow-on capital. The strongest fits are early-stage MedTech teams with defensible IP and a working path from bench to bedside. Geographies: India. Who can apply: Early-stage teams/startups with a validated idea/proof of concept (TRL 3 onwards) working on medical devices, diagnostics, surgical/interventional technologies, or remote monitoring, holding IP or with potential to generate IP. Funding amount: No cash award amount is stated on the official program page. Benefits are in-kind: prototyping lab and equipment access, clinical/hospital validation (Max Healthcare), expert mentorship, CDSCO regulatory guidance, IP filing support, workspace, cloud credits and tools, and investor connects. Run under the aegis of BIRAC EDGE and builds a path to follow-on Government/VC/Angel funding. Targeted Sectors / SDGs: Innovation, Science & Technology · SDG3; SDG9. Deadline: October 5, 2026. Learn more and apply here. OpenAI AI and Teen Development Research Grant Program, OpenAI. *New!* *Closing soon!* OpenAI is opening its AI and Teen Development Research Grant Program to fund independent studies of how generative AI shapes the lives of young people ages 13 to 17. OpenAI wants a stronger evidence base on how teens actually use these tools and what that use does to their social and emotional development, so that product teams, policymakers, and regulators can act on findings rather than assumptions. It seeks work on emotion regulation, relationships, belonging, and the safeguards that keep teens safer, welcoming interdisciplinary teams and any methodology. That it will fund research whose conclusions may not favor AI providers, and prioritizes studies touching ChatGPT, signals a genuine appetite for credible outside scrutiny. The strongest fits are research groups grounded in adolescent development, well-being, and AI safety. Geographies: Global. Who can apply: Researchers aged 18 or older who are affiliated with a research institution or organization, and/or have significant experience relevant to child or adolescent development, well-being, human-computer interaction, AI impacts, or a closely related field. Multiple institutions may collaborate. OpenAI is seeking to fund research rather than for-profit initiatives and will not prioritize for-profit organizations. Funding amount: Individual research grants up to USD $1 million, totaling up to USD $5 million; maximum 10% of each grant for overhead or indirect costs. Targeted Sectors / SDGs: Social Inclusion & Community Wellbeing; Innovation, Science & Technology. Deadline: October 6, 2026. Learn more and apply here.
Tamara Jordan, D.O., MPH, Joins Baptist Health Miami Neuroscience Institute as a Sleep Medicine Physician
September 11, 2026 – Sleep medicine physician Tamara Jordan, D.O., MPH has joined Baptist Health Miami Neuroscience Institute. Her clinical interests include sleep apnea, insomnia, narcolepsy and sleep-related movement disorders. She evaluates and treats sleep disorders that can affect a patient’s overall health, daytime function and quality of life. Dr. Jordan earned her medical degree from […]
AMO Pharma in Collaboration with Population Health Research Institute (PHRI) and Venca Research Inc. Announces FDA Advice on Potential Phase 3 Development Path for AMO-02 in Treatment of Arrhythmogenic Cardiomyopathy (ACM)
/PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with...
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Placental health in late pregnancy linked to childhood ADHD
Attention deficit/hyperactivity disorder (ADHD) in children may be associated with problems with the health of the placenta during late pregnancy, according to a new study by University of Iowa Health Care researchers.
AI-enabled Pelago expands from SUD care to mental health, behavioral addictions
Pelago, a virtual substance use disorder (SUD) provider, has expanded to mental health and behavioral addiction care. | The new Pelago Behavioral Health Platform means co-occurring conditions can be assessed and treated in a single plan. Behavioral addiction programming includes gambling, gaming and binge eating
GLP-1 drugs may protect kidney health in people with bipolar disorder
Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation in adults with bipolar disorder and chronic kidney disease.
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
/PRNewswire/ -- For patients living with chronic blood disorders, access to safe and reliable blood supplies is fundamental to their care journey. Marking the...
Brain cells meant to protect us may be fueling cognitive decline
Scientists have uncovered a surprising cause of age-related cognitive decline involving brain cells previously thought to be entirely beneficial. As these cells become dysfunctional, they can produce abnormal amounts of myelin, disrupting nerve fibers and potentially contributing to worsening memory and thinking skills.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Gentle Brain Ultrasound May Help Ease Delusions in Schizophrenia
NYU Langone pilot study shows that transcranial ultrasound stimulation may safely treat delusions in schizophrenia and schizoaffective disorder. Learn more.
Guided search helps Kentuckians navigate treatment, mental health and recovery resources
A new guided search feature from FindHelpNow.org makes it easier for Kentuckians to find substance use disorder treatment, mental health care and recovery resources that fit their needs.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Scientists Uncover Two Hidden Forms of Disorder in Next-Generation Semiconductors
A study of twisted two-dimensional semiconductors reveals how subtle material disorder can emerge at different spatial scales. Two distinct forms of hidden disorder may influence how ultrathin semiconductors emit light. One extends across relatively large areas of the material, while the other is concentrated around tiny defects. A new theoretical approach offers a way to
Getting the right mental health diagnosis
We talk with Southlake Psychiatry about bipolar disorder, which is often misdiagnosed, for Mental Health Awareness Week.
This “rare” autism-linked genetic disorder may be far more common than scientists thought
A major analysis suggests Phelan-McDermid syndrome, a genetic disorder closely linked to autism, may affect about 1 in 7,300 people and more than 45,000 Americans. Researchers warn that thousands of cases may remain hidden because genetic testing is often not performed, even as targeted treatments move into clinical trials.
Billy Joel Shares Heartbreaking Health Update After Brain Disorder Surgery
The 'Piano Man' singer, 77, was forced to cancel his tour in 2025 due to normal pressure hydrocephalus.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update
Programs are focused on rare obesity disorders associated with the melanocortin 4 receptor (MC4R) pathway, including hypothalamic obesity, Prader-Willi...
Mental Health Treatment by Adults in the United States
Some of our adult patients may have a comorbid diagnosis of a mental, behavioral, or emotional disorder. Of these patients, some may have sought and/or be undergoing treatment. This may…
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Climate change is putting Europe’s brain health at risk
Rising temperatures, poor air quality and the spread of infectious diseases could increase the burden of neurological disorders, with the most vulnerable communities facing the greatest risks.
Scientists believe avian keratin disorder is cause of fishhook beaks in Alaska chickadee population
The virus is causing “the highest concentration of (visible) deformities ever recorded in a wild bird population.”
LIFE-HEALTH-GLP-1S-ALCOHOL-FILEPIC-DMT
A Philadelphia Veterans Affairs doctor is leading a national trial testing whether GLP-1 drugs could help patients with alcohol use disorder.
Billy Joel Shares Update on Brain Disorder, Says Health Isn't That Bad
Billy Joel shares an update on the brain disorder that took him off the road last year, saying his health isn't that bad and people shouldn't worry.
Commentary: Demystifying mental health inpatient stays
I am one of the 68 million Americans living with a mental illness and one of the over 10 million Americans who have been diagnosed with bipolar disorder. Living with these diseases and seeking treatment is highly stigmatized — and newly precarious under the policies of the current federal administration. The best way to break stigma […]
HHS Invests $51 Million to Expand Dental Care for Children with Neurodevelopmental Disorders
The U.S. Department of Health and Human Services , announced $51 million in awards to 28 HRSA-funded health centers to improve access to dental care for children with neurodevelopmental disorders.
Billy Joel can't drive or perform following brain disorder diagnosis
Billy Joel shared health updates following his 2025 brain disorder diagnosis, stating that he has to take “a series of tests” before being able to tour and drive again.
Leucine does more than build muscle. It powers up your cells
The essential amino acid leucine can boost cellular energy production by protecting key proteins on mitochondria from being destroyed. The discovery reveals a new connection between nutrition and metabolism that could eventually lead to new approaches for metabolic disorders and cancer.
Driving Community Health: Bristol Myers Squibb, Emirates Thalassemia Society and Dubai Science Park Host the 6th 'Help Save a Life' Blood Donation Drive
/PRNewswire/ -- For patients living with chronic blood disorders, access to safe and reliable blood supplies is fundamental to their care journey. Marking the...
Community Clinic awarded $3 million federal grant
Springdale-based healthcare provider Community Clinic will receive $3 million from the Health Resources and Services Administration to expand rural substance use disorder prevention, treatment and recovery services in rural areas...
PTSD, Health-Related Social Needs Together Increase Cognitive Risks Significantly in Veterans
A recent study asked a question critically important to VHA clinicians: Are post-traumatic stress disorder (PTSD) and health-related social needs (HRSNs) associated with incident mild cognitive impairment, Alzheimer’s disease and Alzheimer’s disease-related dementias among U.S. veterans?
Forty percent of high school students report binge eating in new CDC survey
About 40% of high school students reported binge-eating in the past month in a new CDC survey, highlighting how widespread this form of disordered eating is among young people.
Virtual SUD support platform Nosis launches to address lifestyle, diet needs
Nosis, a platform supporting substance use disorder (SUD) recovery, is launching from stealth in all 50 states. | The virtual startup leverages labs with health coaches and dietitians to address the biological and metabolic health needs of individuals in recovery.
Can AI solve our mental health access problem?
Last week I asked you what worries you most about AI in health. It was close, but your top answer was “AI giving bad health advice.” Last week’s poll results: You’re in good company. This concern was top of mind at a conference I joined at Stanford last week, where researchers, clinicians, and people who build AI systems spent a day debating trust and safety in health AI. Stepping back, I’m also hearing your emerging concerns about AI’s impact on our well-being generally. I see this as a matter of public health, and we’ll take it in pieces as we learn together. Today we’ll focus on AI chatbots used for therapy for mental health. Early this month, Governor Newsom vetoed Senate Bill 903, California’s most ambitious attempt to regulate AI use for mental health. It’s at the center of active debate, and raises the questions patients, family members, citizens, and voters will face as AI moves deeper into health care. Let’s work through it. What is “AI-based therapy”? It’s really two things: purpose-built mental health apps designed to deliver structured support, and general chatbots like ChatGPT, Claude, and Gemini that people increasingly use for emotional support—even if they weren’t built for it. Spoiler alert: I don’t know whether the shift toward AI therapy is good or bad. The evidence isn’t there yet. But I do know it’s already happening, and I have some ideas about how we can roll it out with safety in mind. The therapy dilemma, in a nutshell Mental health challenges are common, and strain health and well-being across populations. Therapy (interactive dialogue with a trained, empathetic practitioner) helps many people heal. The demand for licensed therapists far exceeds the supply in California, and AI-based therapy can narrow that gap. AI-based therapy remains novel, unproven, and not well tested. Right off the bat, we can see we’re dealing with trade-offs here. Since the main driver of demand for therapy from a robot is lack of access to therapy from a human, we’ll start there. It’s too hard to find and afford a human therapist California is short roughly 55,000 licensed, non-prescribing therapists and counselors, about 40% of what we need. Psychiatrists, who rely on talk therapy as a complement to prescribed medications, are even more scarce. Eight counties have none, and density ranges from 1.7 per 100,000 residents in San Benito County, to 68.1 in Marin County. My wife is a psychiatrist in Marin, and even here access is tight. If it’s hard in the best-supplied county, imagine rural Sierra County, or the San Joaquin Valley. In 2024, more than half of Californians who tried to make a mental health appointment struggled to find a provider who took their insurance, compared with 14% for physical health care. When Senate staff posed as “secret shopper” patients and called 120 mental health providers in Medicare Advantage networks, they landed an appointment less than once for every five tries. Insurers pay behavioral health clinicians about 22% less than medical and surgical clinicians for comparable office visits. On top of that, billing denials and prior authorizations hit hardest at the solo and small practices common in mental health. Psychiatrists opt out of Medicare at the highest rate of any specialty. In many places, a cash practice for therapy fills quickly with patients paying $250 or more an hour, with no insurance paperwork at all. Families who can pay cash find providers more easily. Those who rely on insurance, including Medi-Cal enrollees, older adults, rural residents, and non-English speakers, compete for what’s left. So we can’t pretend the human system works, and we can’t blame people for turning to AI for support when they’re in distress. AI is filling the gap It’s estimated that roughly a quarter of AI users use it for mental health support. If you have internet, it’s available 24/7, it’s cheap, and it speaks your language. Uninsured adults are about twice as likely as insured adults to do it (30% vs. 14%). It feels anonymous in ways that may enable people to ask things they’re unsure or embarrassed about. The largely hidden, personal use makes it hard to study whether it’s actually helping people with their mental health issues, but researchers are trying. Does AI therapy work? A 2026 analysis of nearly 40 randomized trials found chatbots showed a real but small reduction in depression symptoms. But most of these trials were compared to an alternative of no therapy, not a human therapist. So the benefit of AI therapy is probably real, but modest, and mostly untested against the alternative of human contact. We need more studies. Serious concerns OpenAI’s own estimate is that more than a million ChatGPT users each week show signs of suicidal planning or intent. These are high stakes encounters, and AI doesn’t always get it right. That’s partly because a chatbot can sound like a therapist, but it has no license, no duty of care, and it’s not clear who to hold accountable when it gets things wrong. AI is also designed to help users in whatever task they’re seeking to accomplish. People may feel like they’re getting therapy, but they’re mainly getting a convincing conversation. It’s easy for an AI companion to wander into gray areas, like playing along with “creative writing” that may be about the user’s own suicidal intent. Courts are driving safety conversations A wave of lawsuits have been filed on behalf of families claiming that chatbots pushed people they loved toward self-harm, including teens who died by suicide. The first settlements came this year. OpenAI is headquartered in San Francisco, and dozens of cases alleging that ChatGPT drove users to suicide or self-harm are now before a San Francisco judge. Character.ai has filed for bankruptcy after several states brought lawsuits accusing the chatbot of pushing dangerous content to kids. But the technology seems to be improving. Last month, an independent evaluation found that newer AI models “almost never endorse suicide.” That’s progress, but our societal appetite for even one preventable death is very low. So how do we move forward? Finding a middle ground Earlier this month the governor vetoed Senate Bill 903, a bill designed to place guardrails on the use of AI for therapy. The bill would have prohibited any AI-based platform from being advertised as psychotherapy, and would have required a licensed professional to review and approve each encounter where AI was used to support therapeutic decisions. Newsom called it overly broad, since even routine screening questions would have needed clinician sign-off. Knowing we’re already short on mental health providers, requiring human review of AI encounters may not relieve our access problems. Still, the answer isn’t no oversight. Here’s one feasible short term solution. Rather than reviewing each encounter, a licensed clinician can design the guardrails: what counts as a crisis, what triggers an immediate handoff to a human, and what gets sampled for audit each month. The AI runs inside that structure. Conversations get checked, failures get reported, and a real clinician owns the framework. Medicine already has models to learn from. The FDA process for rolling out newly approved medications is an example. After a product reaches patients, we keep watching for adverse events. Patient-facing AI needs the same “digital pharmacovigilance”: systematic tracking of harms, near misses, and the types of groups that get hurt and why. It’s also critical that users know that they can reach a human if they’re in crisis. Most chatbots now include messages like these: Bottom line The rush to use unproven AI tools for mental health support is mostly a workaround, a sign of a health system people can’t get into. We need better access to proven care from licensed clinicians. That takes reimbursement that makes accepting insurance viable, and a bigger workforce. But, built and tested well, AI could be part of the answer. It could be the 2 a.m. check-in when no one else is awake, or a way for patients to practice skills their therapist taught them. It could be the first step to get someone the right level of care, and take paperwork off clinicians’ plates so they spend more time with patients. None of this is simple. The SB 903 veto doesn’t end the debate, and the legislature will be back. In the meantime, those of us using these tools need to stay informed, ask hard questions, and hold the companies building them accountable. I’ll try to do my part, and we’ll keep learning together. Love,Matt P.S. If you or someone you know is struggling with mental health challenges, emotional distress, substance use problems, or just needs to talk, call or text 988- you’ll reach a real person— or chat at 988lifeline.org 24/7. Dr. Matt Willis is the author of Your Local Epidemiologist in California. A California native, he’s served as a primary care physician, CDC epidemiologist, and public health officer for Marin County, where he guided the pandemic response. He lives in Marin with his family and their dogs, Teddy and Ramona. Thank you Cynthia He, MD, PhD, and Parnika Saxena, MD, for their guidance in preparing this article. Cynthia works in an outpatient mental health clinic, treating patients who have Medi-Cal or, sometimes, no insurance. Parnika works in an inpatient psychiatric unit, treating patients with public or private insurance or self-pay ability. All opinions are their own and do not represent their employers.
Health experts stress importance of newborn screening
Screenings look for rare but serious health conditions that may not present right away and detect concerns like metabolic, endocrine and blood disorders.
Scientists find that “perfect” systems may be surprisingly fragile
Complex systems may work better when their parts are not perfectly alike. Northwestern physicists found that carefully balanced variation, or “disorder,” can make networks such as power grids, ecosystems, neurons, and materials more stable. Even random differences sometimes improved stability compared with completely uniform systems. The discovery could help researchers design more resilient technologies and explain why natural systems are so rarely perfectly uniform.
‘I’m Not Allowed to Drive’: Billy Joel Shares Health Update as He Prepares to Sell Vintage Motorcycles
The singer was diagnosed with a brain disorder and stepped away from live performances last year
AltaPointe Health celebrates $15 million BayPointe Hospital expansion
The additional beds are also intended to give children ages 5-19 faster access to care for psychosis, behavioral and mood disorders.
Scientists Grow Partly Human Brains Inside Mice
Breakthrough could speed research into human neurological disorders
Christina Mezes, D.O., Joins Lynn Women’s Health & Wellness Institute as a Urogynecologist
October 1, 2026 – Board-certified obstetrics and gynecology physician and fellowship-trained urogynecologist Christina Mezes, D.O., has joined the Christine E. Lynn Women’s Health & Wellness Institute in Boca Raton, a part of Baptist Health South Florida. Dr. Mezes provides care for women with pelvic floor disorders, including pelvic organ prolapse and urinary and fecal incontinence. […]
Yale School of Medicine On the Science of Childhood Anxiety, Say, Anxiety Disorders Are the Most Common Mental Health Challenges In Youth
Credit: Matt Bradbury October 5, 2026 - By Isabella Backman - Anxiety disorders are the most common mental health challenges in youth. Left untreated, they can disrupt the lives of both children and their families. The good news is that with intervention, most children will overcome these conditions. Across Yale School of Medicine, scientists are working to understand anxiety at every level, from common anxious behaviors to molecular biomarkers in the brain. They are using their findings to develop and disseminate new evidence-based treatments for childhood anxiety. Today, the go-to treatment for childhood anxiety disorders is cognitive behavioral therapy (CBT). This is a form of psychotherapy that teaches children skills for confronting anxious thoughts and helps them practice managing situations that cause anxiety. While it is the gold-standard treatment backed by considerable scientific evidence, up to 50% of children will not see sufficient benefit from CBT alone. Wendy Silverman, PhD, Alfred A. Messer Professor in the Child Study Center, co-directs the Anxiety and Mood Disorders Program alongside Eli Lebowitz, PhD, associate professor in the Child Study Center. One of their main interests is learning how to improve outcomes beyond CBT. “We’re developing cutting-edge, research-based knowledge that can reduce the suffering that anxiety causes children and their families,” says Silverman. Changing parent behavior YSM experts are investigating how to improve CBT outcomes for children by involving the parents. Silverman’s research has uncovered two main components of parent intervention that improve childhood anxiety: not enabling children to completely avoid the things that make them anxious and taking steps to enhance their autonomy. Parents may unintentionally reinforce their child’s anxiety by allowing them to avoid what makes them anxious. They also may unintentionally limit the children’s sense of autonomy by being overly intrusive. “One of the things that we take pride in is that we’ve focused on trying to understand what parents need to do, and to test our ideas and see if changing the parents’ behaviors is enhancing the effects of CBT,” Silverman says. “Our findings thus far suggest that they do." As much as CBT can be helpful, it can also be challenging to get one’s child to do the necessary steps for CBT to work. This is one important reason why Lebowitz created a novel intervention program for parents named Supportive Parenting for Anxious Childhood Emotions (SPACE). Existing intervention programs often teach parents to act as therapists for their child, such as training them on how to practice breathing exercises. “It makes sense, but this doesn’t work very well in practice,” says Lebowitz. “And part of the reason, I think, is that it’s not easy to get your kid to do things, especially if they’re not excited about doing it.” SPACE is unique because it focuses entirely on parent involvement and changing parental behavior—children are not involved in the sessions. For example, parents learn how to use supportive messages that convey confidence that their child can tolerate and manage distress. “It might sound like a parent saying to a child, ‘I get that this is really hard for you, but I know that you can handle it,’” Lebowitz says. The program also works with parents to identify the ways in which they are accommodating anxious behaviors. “We’ll pick one thing that parents are doing that is an accommodation and help them make a detailed plan for how they’re going to change that,” Lebowitz explains. Treating Anxiety in Children and Adolescents Much of the existing research on SPACE has focused on parents of children under age 14. Ongoing studies are now exploring its use with parents of older teens. “Both anxiety and accommodation can interfere with normative developmental shifts during the teen years, including increased autonomy and individuation from parents,” says Rebecca Etkin, PhD, associate research scientist in the Child Study Center. “In this sense, SPACE may be particularly well-suited for anxious teens and their parents. We want to see whether it is effective during this distinct developmental window.” Unfortunately, many families in need of CBT face barriers, including limited availability of services and geographic constraints. One way to improve access is digital interventions. Silverman and her team are developing an evidence-based digitized intervention program for parents that they can access directly from their computer or smart phone. “The work we’re doing will be one of the very few parent interventions that is digitized and importantly tested for effectiveness,” she says. Creating interventions for anxiety-related challenges Silverman and Lebowitz recently received a generous gift to develop and test other interventions that help parents reduce other child anxiety-related behavioral and emotional difficulties, such as restrictive eating and unexplained somatic symptoms. One of these projects in particular focuses on understanding the risks of social media and its potential benefits, including offering a sense of connection. “A lot of research has focused on the idea that social media is harmful and the less of it the better,” says Lebowitz. “But we actually see is that this is not quite right—there are negatives, but there are also positives. So, we’re trying to get a little bit more nuanced of a picture.” The team is working with teens with social anxiety and their parents over an extended period to better understand their social media habits and how their anxiety levels affect engagement with different platforms. The teens will answer questions sent to an app on their phones about mood and social media usage in an effort to capture emotional responses as they unfold. “We hope to develop interventions that can help make the best of social media while protecting against the more problematic effects,” Lebowitz says. The brain’s role in anxiety Researchers are also testing therapies to address anxiety at the neurological and molecular levels. In collaboration with Dylan Gee, PhD, professor of psychology in Yale's Faculty of Arts and Sciences, and Hilary Blumberg, MD, John and Hope Furth Professor of Psychiatric Neuroscience at Yale School of Medicine, Lebowitz and Silverman are using brain imaging to identify changes in a child’s brain before and after parents enroll in SPACE. In one study, children viewed anxiety-inducing images while undergoing magnetic resonance imaging (MRI); the researchers conducted scans with and without the children’s parents nearby. Before SPACE, children’s brains were better able to activate the regulatory circuitry needed to turn off an anxious response when their parents were nearby. But after SPACE, children could activate this circuitry even without the parent around. “As parents work on gradually reducing some of their accommodations, you can see a child get better at regulating their own fear system in the brain,” Lebowitz says. “It’s remarkable.” Research into the molecular underpinnings of anxiety can also inform new childhood anxiety treatments. In a recent study, Lebowitz, Silverman, and Flora Vaccarino, MD, Harris Professor in the Child Study Center, discovered that a protein known as fibroblast growth factor 2 (FGF2) could be protective from the toxic effects of stress. FGF2 levels in children and their parents were linked to the children’s risk of developing anxiety and depression, the study showed. The findings could help explain why some children who are exposed to early life trauma such as poverty or abuse are more prone to developing mental health disorders. And FGF2 could be a target for treatment. “This is very novel because it starts to give a clue to what is the molecular chain that connects those lived experiences to the actual psychological outcomes,” Lebowitz says. New ways to study and treat childhood anxiety Michael Crowley, PhD, associate professor in the Child Study Center, collaborates with Silverman and Lebowitz to study the role that attention plays in development and maintenance of childhood anxiety. There is a large body of research that shows that anxious children, like anxious adults, are prone to focus on threatening stimuli such as angry faces compared with neutral faces. This has led to innovative interventions that involve attention retraining. The idea is that if experts train children to look away from threatening stimuli, it may reduce their anxiety—especially children with social anxiety who are most prone to attend to threats. The researchers have just completed a clinical trial for attention retraining with 10- to 14-year-olds with social anxiety disorders and are currently analyzing the findings. Besides this innovative attention retraining research, as Crowly notes, “I like to design tasks that are engaging to kids,” Crowley says. “My goal is to assess something without the kids knowing what we are assessing.” With this goal in mind, Crowley has created a virtual game, named Boom, to study threat processing in children with anxiety disorders. The game is similar to that of hot potato—the child and three digital players take turns virtually passing a ball to each other’s gloves. At some point, the ball turns into a bomb, and as the bomb lands in each player’s glove, the outline of the glove turns yellow. The goal is to avoid having the bomb go off in your glove. What isn’t obvious is that the game is designed to measure different types of threatening stimuli, both ambiguous and direct. In the game, the direct threat occurs as the bomb is traveling towards your glove. The ambiguous threat is the yellow outlined glove as it is unknown where the bomb will travel next. While children play the game, Crowley’s team measures their brain activity using electroencephalography (EEG). The researchers have discovered that in kids with anxiety, the brain reacts more strongly to ambiguous threats than it does in their peers, but less strongly to direct threats. They believe that the initial abnormally large brain response to not knowing where the bomb is going impairs the brain's ability to properly respond when the threat is actually traveling the child’s way. “The brains of children with anxiety are unable to differentiate between threats you need to do something about and those that are not your problem.” Michael Crowley, PhD, develops innovative games for studying anxiety in children and adolescents.Credit: Matt Bradbury Based on these insights, Crowley hopes to study whether interventions like attention training could restore appropriate threat processing. Crowley’s team is also working on a test called the Balloon Risk Avoidance Task, which evaluates risk-taking and avoidance behaviors. It features a digital balloon that is full of air and about to burst. Kids have six seconds to let air out of the balloon. The more air they let out, the less risk they face that the balloon will pop. But at the same time, the balloon becomes less valuable as it deflates. “The more air you keep in the balloon, the more points you get,” Crowley explains. So far, the researchers have found that when the balloons pop unexpectedly, teens with social anxiety show distinct brain responses. Studying these responses can help psychologists understand the underlying pathways driving the various manifestations of anxiety. The genetics of anxiety When Thomas Fernandez, MD, associate professor in the Child Study Center and of psychiatry, was still in training, there was a lot of excitement about understanding the genetics associated with autism spectrum disorder. Since then, scientists have identified around 250 genes associated with autism. The genetic contribution to anxiety disorders, on the other hand, has historically received less attention. Anxiety is less heritable than autism, but the genetic contribution for anxiety disorders that emerge in childhood may be higher than for anxiety disorders overall. While scientists estimate the heritability of anxiety disorders in general to be around 30% to 50%, some studies suggest higher heritability for certain childhood-onset anxiety presentations. “I saw firsthand how researchers in the field went about finding vulnerability genes for autism,” Fernandez says. “So, we’re using a very similar playbook for childhood anxiety.” “I saw firsthand how researchers in the field went about finding vulnerability genes for autism. So, we’re using a very similar playbook for childhood anxiety.” Thomas Fernandez, MD Associate Professor In the Child Study Center and in Psychiatry Now, Fernandez and Emily Olfson, MD, PhD, assistant professor in the Child Study Center, are studying children and their parents to identify genetic changes that are present in the child but not the parents, known as “de novo mutations.” “All of us have some de novo mutations—maybe about 50 to 100 sprinkled throughout the genome,” Olfson says. “But when they occur within the coding regions of genes, they can be really disruptive.” Previous research shows that people with autism have higher rates of damaging de novo mutations than the general population. In 2022, Olfson, Lebowitz, Silverman, and Fernandez published a study on 68 children and their families that found that children with anxiety had similarly high levels of these mutations. Studying de novo mutations can help point the researchers to where they should be looking for genes associated with anxiety. “The end game is using the genes to steer us toward the right part of biology that we can then target to come up with better treatments,” Fernandez says. Building on those findings, the team is now studying more families to better understand how these de novo mutations, along with other genetic and environmental factors, shape pediatric anxiety disorders. They recently received a National Institutes of Health grant to enroll 750 new families over the next five years. Olfson is the principal investigator, with co-investigators Lebowitz, Fernandez, Silverman, and Shuangge Steven Ma, PhD, department chair and professor of biostatistics at Yale School of Public Health. Neurodevelopment, Risk Genes, and Mental Health Conditions - The Olfson Lab Joel Gelernter, MD, Foundations Fund Professor of Psychiatry, is interested in how different anxiety disorders differ genomically. “We are studying social phobia, panic disorder, and generalized anxiety disorder, working to understand why people differ in their risk to these specific anxiety disorders and evaluating various risk factors,” he says. Gelernter was recently involved in one of the largest studies to date of the genomics underlying anxiety disorder. The study included around 122,000 people with anxiety disorders and around 730,000 without. It found that some genetic differences associated with anxiety were linked to signaling that helps reduce overactivity in the nervous system. Many anxiety medications available today work by targeting this process. “It’s nice when the biology that you get out of a large genome-wide study ratifies things that we already know because that can help increase confidence in further findings from the study,” Gelernter says. Uncovering the neurobiology of psychiatric disorders John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and chair of the Department of Psychiatry, is interested in the neurobiology of psychiatric disorders, including post-traumatic stress disorder (PTSD), of which anxiety is a major symptom. In the late 1980s, Krystal’s team discovered that the drug yohimbine activated symptoms in patients with PTSD. “This was the first time we could link a specific biological mechanism to the symptoms of PTSD,” Krystal says. At the time, he adds, this finding was highly controversial. “A lot of people felt that PTSD was a purely psychological syndrome that didn’t have an underlying biology.” Since then, Krystal has dived deep into understanding the neurobiology of PTSD to learn how to better treat it. His team is evaluating the use of ketamine and psychedelics. These would be among the first treatments to be developed specifically for PTSD. They may also be applicable for other disorders including anxiety disorders, Krystal adds. An important gap in PTSD treatment is the absence of biological tests that inform how to best help patients manage their PTSD symptoms. A doctor doesn’t diagnose cancer based on how they feel. Rather, they use tests of the biology of the cancer to determine the best course of treatment. “And we can’t do that in any psychiatric disorder other than Alzheimer’s disease,” Krystal says. “But now we are building a foundation for this approach to the treatment of anxiety disorders for the first time.” Source: Yale School of Medicine
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Vanderbilt Health-led team maps gene variants that can cause sudden death
Vanderbilt Health researchers have created a “map” of 1,757 genetic variations that can trigger a life-threatening heart rhythm disorder called long QT syndrome.
Pope Leo XIV's October prayer intention is 'for mental health ministry'
More than a billion people worldwide live with a mental disorder, while public spending on mental health accounts for barely 2% of health budgets.
Health Minute: Signs of seasonal affective disorder
Millions of Americans are estimated to experience Seasonal Affective Disorder. CNN's Mandy Gaither has more on the signs to watch out for and dispels myths about one of the treatments for it. (Source: CNN)
Climate change is putting Europe’s brain health at risk
Rising temperatures, poor air quality and the spread of infectious diseases could increase the burden of neurological disorders, with the most vulnerable communities facing the greatest risks.
Poitras Center to fuel early careers of 50 young scientists dedicated to psychiatric disorders research
Patricia and James Poitras launched a fellowship program for MIT graduate students and postdocs studying major mental illness, expanding their philanthropy to directly support early-career scientists.
Advancing Hope: 15th ISFTD Conference Brought the Latest Updates in FTD Science to Philadelphia
AFTD and FTD Disorders Registry staff attended the 15th annual ISFTD conference in Philadelphia to learn the latest updates in FTD science.
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
Supports Optimi’s planned Phase 2 psilocybin trial in major depressive disorder and Phase 3 MDMA trial in PTSDVANCOUVER, British Columbia, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) ("Optimi" or the "Company"), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced the appointment of Michael Blough, Ph.D., as Chief Clinical Development Officer. Dr. Blough has significant experience leading Health Ca
Haoye Qin: Turning disorder into an advantage in nanophotonics
A 2026 Nanophotonics Early Career Awardee, Qin is harnessing topology and engineered disorder to develop compact optical technologies.
Billy Joel shares health update amid brain disorder: ‘I know people are worried about me’
Joel was diagnosed with normal pressure hydrocephalus last year.
RWJBarnabas Health Celebrates 10 Years of the Tackling Addiction Task Force and Peer Recovery Program
Celebration at Cooperman Barnabas Medical Center recognizes a decade of comprehensive programs and compassionate care for those affected by substance use disorder.
Pfizer makes ‘business decision’ to end phase 2 trial of autoimmune drug as program’s future uncertain
Pfizer has called time on a phase 2 trial of its CXCR5 antibody in an autoimmune blood disorder, with the company tight-lipped on whether this marks the end of the road for the asset. The Big Pharma had been evaluating the therapy, dubbed PF-06835375, in a phase 2 study of 61 patients with primary immune thrombocytopenia (ITP) that kicked off in 2022, according to the federal trials register. However, Pfizer confirmed to Fierce on Monday that this study had been terminated “due to a business decision.” “The decision to terminate the trial was not based on any safety concerns,” a spokesperson pointed out. At time of publication, PF-06835375 remained listed on Pfizer’s website for both ITP and lupus. A phase 1 study in lupus wrapped up in 2022, according to the trials database. ITP is an autoimmune disorder characterized by a low platelet count. Novartis was at one point evaluating its B-cell-depleting antibody ianalumab—recently approved as Fabhalta to treat immunoglobulin A nephropathy—as a potential treatment ITP. But the therapy struggled to demonstrate a benefit in the clinic for this indication. When contacted by Fierce, Pfizer wouldn’t confirm whether all work on PF-06835375 has been halted, and whether the company has any other plans to explore C-X-C chemokine receptor type 5 (CXCR5) as a mechanism. CXCR5 is found in blood cancers such as diffuse large B-cell lymphoma and mantle cell lymphoma chemokine receptor. However, there is little expression in normal tissue, which has led some drug developers to explore its potential. Vincerx Pharma had at one point been planning to take an anti-CXCR5 ADC into the clinic to treat B-cell malignancies, but that ambition was scrapped due to cash constraints. Where Big Pharma is placing its bets is one of the hot topics being discussed at Fierce Biotech's high-impact event in London next month. Find out more information and register by clicking on the banner below: [ ](https://qtxasset.com/quartz/qcloud5/media/image/where_big_pharma_is_placing_its_bets.png?VersionId=B8JrRbJ.pFUSK1pJgjeWHLGm_18RdLAy)
Darby Fox warns of smartphone, AI dangers to youth mental health
Child and adolescent family therapist Darby Fox warns of youth mental health risks linked to early smartphone ownership and AI companionship. Fox explains studies connecting technology to higher eating disorder risks and loneliness.
Health records link ADHD to more than fourfold higher risk of later cognitive impairment
A new study led by University of Pittsburgh School of Medicine researchers finds that adults with attention-deficit/hyperactivity disorder (ADHD) face a significantly higher risk of developing dementia ...
Study finds gambling disorder diagnoses rose in states with legal sports betting
A new study found that diagnosed gambling disorders increased 61% in states that have legalized sports betting, including Pennsylvania and New Jersey.
Be a Friend Campaign Supports Child Cancer Program at Lee Health Golisano Children’s - Florida Hospital News and Healthcare Report
Oct. 14, 2026 – Throughout Childhood Cancer Awareness Month, Southwest Florida community united to support local children facing cancer and blood disorders through the Be a Friend campaign benefiting Barbara’s […]
Navigating digestive disorders: tips and resources for managing gut health
For tens of millions of Americans, digestive issues and unpredictable gut health are far more than an occasional inconvenience—they are daily disruptions.
Billy Joel Shares Heartbreaking Health Update After Brain Disorder Surgery
The 'Piano Man' singer, 77, was forced to cancel his tour in 2025 due to normal pressure hydrocephalus.